v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
 Consolidated net income $ 7,537 $ 9,329
 Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 3,447 3,536
Net change in operating right-of-use assets and lease liabilities 370 15
(Recovery) provision for credit losses (183) 2,608
Abandoned patents 3
Deferred tax expense 154 878
Changes in operating assets and liabilities, net:    
Accounts, medical and management fee receivable(s) (5,352) (7,140)
Notes receivable – related party (37) (39)
Inventories (19) 8
Prepaid expenses and other current assets 48 (1,093)
Other assets (415) 6
Accounts payable 985 (631)
Other current liabilities (3,248) (549)
Finance lease liabilities (163) (153)
Customer deposits 327 111
Other liabilities (14) 159
Net cash provided by operating activities 3,440 7,045
Cash Flows from Investing Activities:    
Purchases of property and equipment (2,435) (3,145)
Cost of non-compete contract (500)
(Purchase) Proceeds from short-term investments (2) 13
Cost of patents (1) (25)
Net cash used in investing activities (2,938) (3,157)
Cash Flows from Financing Activities:    
Repayment of borrowings and capital lease obligations (114)
Sale of noncontrolling interest 132
Purchase of treasury stock (1,806)
Distributions to noncontrolling interests (3,186) (4,184)
Net cash used in financing activities (3,186) (5,972)
 Net Decrease in Cash and Cash Equivalents (2,684) (2,084)
Cash and Cash Equivalents - Beginning of Period 56,334 56,341
Cash and Cash Equivalents - End of Period $ 53,650 $ 54,257